Abstract
The goal of this study was to determine if novel porphyrins protect cultured cortical neurons from excitotoxic NMDA exposure or oxygen-glucose deprivation (OGD), which model key aspects of cerebral ischemia. Porphyrins were chosen based on conventional and unconventional criteria. Metalloporphyrin catalytic antioxidants possessing a redox-sensitive metal core can exhibit potent and wide-ranging catalytic antioxidant abilities, which are conventionally believed to underlie neuroprotection. We report here that a recent-generation potent peroxynitrite decomposition catalyst, FP-15, protected a majority of neurons against OGD and NMDA toxicity, without suppressing NMDA-mediated intracellular Ca2+ (Cai2+) elevations or whole-cell currents. We have previously shown that neuroprotection against OGD and NMDA toxicity correlated with an ability to suppress neurotoxic Cai2+ elevations and not antioxidant ability. We now evaluate if this unconventional mechanism extends to inert metal-free porphyrins. Neuron cultures were completely protected against OGD and NMDA toxicity by H2-meso-tetrakis(3-benzoic acid)porphyrin (H2-TBAP(3)) or H2-meso-tetrakis(4-sulfonatophenyl)porphyrin (H2-TPPS(4)), although only H2-TPPS(4) suppressed (completely) ...Continue Reading
References
Aug 27, 1999·Trends in Pharmacological Sciences·M Patel, B J Day
Aug 25, 2001·Journal of Neurochemistry·Q Y LiM Patel
Oct 26, 2001·Journal of Neurochemistry·J L TrackeyS J Hewett
Dec 26, 2001·Chemical Reviews·D P Riley
Jul 2, 2002·Journal of Neurochemistry·Xiaopeng ZhangRobert S B Clark
Oct 4, 2002·Free Radical Biology & Medicine·Huaxin ShengDavid S Warner
Oct 29, 2002·The Annals of Thoracic Surgery·Cesario BianchiFrank W Sellke
Jun 20, 2003·American Journal of Physiology. Cell Physiology·Joseph S TauskelaPaul Morley
Jun 24, 2003·Journal of Inorganic Biochemistry·Remy KachadourianBrian J Day
Oct 3, 2003·British Journal of Pharmacology·Carolina MuscoliDaniela Salvemini
Dec 12, 2003·Biochemical Pharmacology·Remy KachadourianBrian J Day
Jun 16, 2004·British Journal of Pharmacology·Meenakshisundaram ThiyagarajanShyam Sundar Sharma
Jun 19, 2004·Drug Discovery Today·Brian J Day
Jun 30, 2004·Free Radical Biology & Medicine·Ayako Okado-MatsumotoIrwin Fridovich
Jul 15, 2004·Dalton Transactions : an International Journal of Inorganic Chemistry·Ines Batinić-HaberleIrwin Fridovich
Oct 16, 2004·Journal of Neurosurgery·Shyam S SharmaChaman L Kaul
Oct 16, 2004·Synapse·Dario Santiago-LópezAbel Santamaría
Dec 22, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Irina G ObrosovaCsaba Szabó
Feb 11, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Brian J Day, Chirag Kariya
Aug 6, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Joseph S TauskelaPaul Morley
Aug 23, 2005·Neuroscience·V Pérez-De La CruzA Santamaría
Citations
Jan 26, 2011·Shock·Francisco Garcia SorianoCsaba Szabó
Sep 22, 2009·Neuroscience Letters·Joseph S Tauskela, Eric Brunette
Jul 5, 2008·Free Radical Biology & Medicine·Ivan SpasojevićInes Batinić-Haberle
Aug 10, 2006·Journal of Neurochemistry·Joseph S TauskelaPaul Morley
Jan 13, 2015·Expert Opinion on Therapeutic Patents·Lauren M Slosky, Todd W Vanderah
Jun 29, 2017·Brain Research Bulletin·Kristina RamdialAlvaro G Estevez
Aug 2, 2007·Nature Reviews. Drug Discovery·Csaba SzabóRafael Radi